annual FCF:
-$338.69M-$17.07M(-5.31%)Summary
- As of today (July 1, 2025), TVTX annual free cash flow is -$338.69 million, with the most recent change of -$17.07 million (-5.31%) on December 31, 2024.
- During the last 3 years, TVTX annual FCF has fallen by -$299.74 million (-769.70%).
Performance
TVTX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$53.98M-$8.70M(-19.21%)Summary
- As of today (July 1, 2025), TVTX quarterly free cash flow is -$53.98 million, with the most recent change of -$8.70 million (-19.21%) on March 31, 2025.
- Over the past year, TVTX quarterly FCF has increased by +$71.49 million (+56.98%).
- TVTX quarterly FCF is now -302.25% below its all-time high of $26.69 million, reached on September 30, 2021.
Performance
TVTX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$267.19M+$71.49M(+21.11%)Summary
- As of today (July 1, 2025), TVTX TTM free cash flow is -$267.19 million, with the most recent change of +$71.49 million (+21.11%) on March 31, 2025.
- Over the past year, TVTX TTM FCF has increased by +$70.81 million (+20.95%).
Performance
TVTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TVTX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.3% | +57.0% | +20.9% |
| 3 y3 years | -769.7% | +10.9% | -318.9% |
| 5 y5 years | -359.1% | -59.8% | -273.9% |
TVTX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -769.7% | at low | -19.2% | +57.0% | -134.2% | +30.1% |
| 5 y | 5-year | -769.7% | at low | -302.3% | +57.0% | -586.1% | +30.1% |
| alltime | all time | <-9999.0% | at low | -302.3% | +57.0% | <-9999.0% | +30.1% |
TVTX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$53.98M(+19.2%) | -$267.19M(-21.1%) |
| Dec 2024 | -$338.69M(+5.3%) | -$45.28M(-10.7%) | -$338.69M(-8.2%) |
| Sep 2024 | - | -$50.70M(-56.8%) | -$368.74M(-3.5%) |
| Jun 2024 | - | -$117.24M(-6.6%) | -$382.10M(+13.0%) |
| Mar 2024 | - | -$125.47M(+66.6%) | -$338.00M(+5.1%) |
| Dec 2023 | -$321.61M(+49.8%) | -$75.33M(+17.6%) | -$321.61M(+5.5%) |
| Sep 2023 | - | -$64.06M(-12.4%) | -$304.92M(+5.8%) |
| Jun 2023 | - | -$73.13M(-33.0%) | -$288.17M(+9.5%) |
| Mar 2023 | - | -$109.08M(+86.0%) | -$263.15M(+22.6%) |
| Dec 2022 | -$214.66M(+451.2%) | -$58.65M(+24.0%) | -$214.66M(+14.1%) |
| Sep 2022 | - | -$47.31M(-1.7%) | -$188.09M(+64.9%) |
| Jun 2022 | - | -$48.12M(-20.6%) | -$114.09M(+78.9%) |
| Mar 2022 | - | -$60.59M(+88.9%) | -$63.79M(+63.8%) |
| Dec 2021 | -$38.94M(-76.0%) | -$32.08M(-220.2%) | -$38.94M(-68.7%) |
| Sep 2021 | - | $26.69M(+1119.2%) | -$124.62M(-17.7%) |
| Jun 2021 | - | $2.19M(-106.1%) | -$151.49M(-7.9%) |
| Mar 2021 | - | -$35.74M(-69.6%) | -$164.56M(+1.2%) |
| Dec 2020 | -$162.59M(+120.4%) | -$117.75M(>+9900.0%) | -$162.59M(+205.0%) |
| Sep 2020 | - | -$180.00K(-98.3%) | -$53.31M(-25.4%) |
| Jun 2020 | - | -$10.89M(-67.8%) | -$71.47M(-14.0%) |
| Mar 2020 | - | -$33.77M(+298.6%) | -$83.08M(+12.6%) |
| Dec 2019 | -$73.78M(+65.2%) | -$8.47M(-53.8%) | -$73.78M(+1.4%) |
| Sep 2019 | - | -$18.34M(-18.5%) | -$72.74M(+17.0%) |
| Jun 2019 | - | -$22.50M(-8.1%) | -$62.14M(+34.7%) |
| Mar 2019 | - | -$24.47M(+229.3%) | -$46.14M(+3.3%) |
| Dec 2018 | -$44.66M(+576.0%) | -$7.43M(-4.0%) | -$44.66M(+8.9%) |
| Sep 2018 | - | -$7.74M(+19.2%) | -$41.02M(+33.1%) |
| Jun 2018 | - | -$6.49M(-71.8%) | -$30.82M(+40.9%) |
| Mar 2018 | - | -$22.99M(+506.0%) | -$21.87M(+231.1%) |
| Dec 2017 | -$6.61M | -$3.79M(-254.0%) | -$6.61M(-57.5%) |
| Sep 2017 | - | $2.46M(+0.7%) | -$15.54M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $2.45M(-131.7%) | -$16.16M(-4.5%) |
| Mar 2017 | - | -$7.72M(-39.3%) | -$16.92M(+10.1%) |
| Dec 2016 | -$15.37M(+82.5%) | -$12.72M(-791.1%) | -$15.37M(+94.1%) |
| Sep 2016 | - | $1.84M(+9.3%) | -$7.92M(-32.9%) |
| Jun 2016 | - | $1.68M(-127.3%) | -$11.80M(+68.1%) |
| Mar 2016 | - | -$6.17M(+16.9%) | -$7.02M(-16.6%) |
| Dec 2015 | -$8.42M(-83.1%) | -$5.28M(+158.5%) | -$8.42M(-31.7%) |
| Sep 2015 | - | -$2.04M(-131.6%) | -$12.32M(-52.5%) |
| Jun 2015 | - | $6.46M(-185.4%) | -$25.94M(-45.2%) |
| Mar 2015 | - | -$7.57M(-17.5%) | -$47.35M(-5.0%) |
| Dec 2014 | -$49.81M(+115.3%) | -$9.18M(-41.4%) | -$49.81M(-8.3%) |
| Sep 2014 | - | -$15.66M(+4.8%) | -$54.31M(+31.4%) |
| Jun 2014 | - | -$14.95M(+49.0%) | -$41.32M(+44.5%) |
| Mar 2014 | - | -$10.03M(-26.6%) | -$28.59M(+23.5%) |
| Dec 2013 | -$23.14M(+488.8%) | -$13.67M(+412.3%) | -$23.14M(+144.3%) |
| Sep 2013 | - | -$2.67M(+20.3%) | -$9.47M(+39.2%) |
| Jun 2013 | - | -$2.22M(-51.7%) | -$6.80M(+48.3%) |
| Mar 2013 | - | -$4.59M(<-9900.0%) | -$4.59M(<-9900.0%) |
| Dec 2012 | -$3.93M(<-9900.0%) | - | - |
| Nov 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2012 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Feb 2012 | $0.00(-100.0%) | - | - |
| Nov 2011 | - | $0.00(0.0%) | -$600.00(-14.3%) |
| Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
| May 2011 | - | $0.00(-100.0%) | -$700.00(0.0%) |
| Feb 2011 | -$700.00 | -$600.00(+500.0%) | -$700.00(+600.0%) |
| Nov 2010 | - | -$100.00(<-9900.0%) | -$100.00(<-9900.0%) |
| Aug 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2010 | - | $0.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual free cash flow?
- What is the all time high annual FCF for Travere Therapeutics?
- What is Travere Therapeutics annual FCF year-on-year change?
- What is Travere Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Travere Therapeutics?
- What is Travere Therapeutics quarterly FCF year-on-year change?
- What is Travere Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Travere Therapeutics?
- What is Travere Therapeutics TTM FCF year-on-year change?
What is Travere Therapeutics annual free cash flow?
The current annual FCF of TVTX is -$338.69M
What is the all time high annual FCF for Travere Therapeutics?
Travere Therapeutics all-time high annual free cash flow is $0.00
What is Travere Therapeutics annual FCF year-on-year change?
Over the past year, TVTX annual free cash flow has changed by -$17.07M (-5.31%)
What is Travere Therapeutics quarterly free cash flow?
The current quarterly FCF of TVTX is -$53.98M
What is the all time high quarterly FCF for Travere Therapeutics?
Travere Therapeutics all-time high quarterly free cash flow is $26.69M
What is Travere Therapeutics quarterly FCF year-on-year change?
Over the past year, TVTX quarterly free cash flow has changed by +$71.49M (+56.98%)
What is Travere Therapeutics TTM free cash flow?
The current TTM FCF of TVTX is -$267.19M
What is the all time high TTM FCF for Travere Therapeutics?
Travere Therapeutics all-time high TTM free cash flow is $0.00
What is Travere Therapeutics TTM FCF year-on-year change?
Over the past year, TVTX TTM free cash flow has changed by +$70.81M (+20.95%)